If the filing person has previously filed a statement on Schedule 13G to report the acquisition that is the subject of this Schedule 13D, and is filing this schedule because of §§ 240.13d-1(e), 240.13d-1(f) or 240.13d-1(g), check the following box.

The information required on the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).




schemaVersion:


SCHEDULE 13D




Comment for Type of Reporting Person:
(1) Of the 11,986,524 ordinary shares reported as beneficially owned with sole voting and dispositive power, 135,000 ordinary shares reported are issuable upon exercise of options for the purchase of ordinary shares, which are exercisable within 60 days of October 28, 2026. This number does not include 800,000 ordinary shares that are issuable upon exercise of warrants, which are not currently exercisable due to certain beneficial ownership limitations. (2) Row 13 is calculated based on 86,091,495 ordinary shares, which includes (i) 85,956,495 ordinary shares outstanding as of October 27, 2026 and (ii) 135,000 ordinary shares issuable upon exercise of options for the purchase of ordinary shares, which are exercisable within 60 days of October 28, 2026.


SCHEDULE 13D


 
Senn Nikolaus Beat
 
Signature:/s/ Senn Nikolaus Beat
Name/Title:Individual
Date:10/28/2026